Where does Cordio Medical Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cordio Medical Ltd. ranks #24,143 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cordio Medical Ltd. hold?

Cordio Medical Ltd. holds 11 US utility patents granted between 2020 and 2025, spanning 7 technology areas.

What is Cordio Medical Ltd.'s Innovation Score?

Cordio Medical Ltd. has an Innovation Score of 42.9 out of 100 (top 29% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Cordio Medical Ltd.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Cordio Medical Ltd..

What does claim depth mean for Cordio Medical Ltd.'s patents?

Cordio Medical Ltd.'s patents average 31.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cordio Medical Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cordio Medical Ltd.

Q: What technology areas does Cordio Medical Ltd. focus on?

Cordio Medical Ltd.'s top technology area is G10L (Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding) with 11 patents, ranking #258 of 1,620 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 11 granted patents across 7 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G10L (Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cordio ranks #24,143 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 7 technology areas.

#24,143
of 49,997 US assignees by volume: Top 29%
by Innovation Score (42.9/100): 31.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R24143 · Foreign Corporation #24,143 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 11 grants
MID-PACK #24,143/49,997
PHOTO-FINISH Conductix Wampfler…
CPC-NARROW G10L · 7 areas
INNOV-PAR 42.9/100
CLAIMS-DENSE 31.8 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Conductix Wampfler France (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cordio’s 42.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (20%) Velocity 10.0 pts (23%) Breadth 9.4 pts (22%) Claim depth 15.0 pts (35%)

Qualcomm Incorporated · highest

85
Cordio Medical · this assignee

43
3D Lighting… · lowest

7

What this shows Cordio's Innovation Score is 42.9/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cordio?

Each dot is one of Cordio’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cordio’s own 31.8 claims/patent is ABOVE the 12.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cordio vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cordio's grants concentrate

Cordio Medical Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under G10L (Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding). Peak complete grant year is 2022 (3 grants) versus a trough of 2 in 2020. By volume, Cordio sits between Conductix Wampfler France and Coster Tecnologie Speciali S.p.A..

Cordio's three-year grant acceleration

Cordio Medical Ltd. shows 6 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Conductix Wampfle…

11
Contitech MGW

11
Contitech Techno-…

11
Continuum Dynamics

11
Corelase Oy

11
Corent Technology

11
Coriant Advanced…

11
Coster Tecnologie…

11
Cordio Medical ◀

11

What this shows Cordio holds 11 patents at rank #24,160, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cordio

By rank, the assignees closest to #24,160 in granted patent volume.

Leaders in G10L (Speech Analysis Techniques OR Speech Synthesis)

Other assignees with the most granted patents in Cordio's primary technology class.

Cordio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 29% higher than 71% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Cordio Medical Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	18.2%
2021	2	18.2%
2022	3	27.3%
2023	3	27.3%
2025partial year	1	9.1%

Which technologies does Cordio Medical Ltd. patent most?

G10L - Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding 11

A61B - DIAGNOSIS; SURGERY; Identification 11

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 4

G06F - Electric Digital Data Processing 2

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

G06N - Computing Arrangements Based ON Specific Computational Models 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cordio Medical Ltd.'s patent record in context - here's where to go next.

Cordio Medical Ltd.'s lead technology class is G10L (Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding), 100% of its portfolio - see every assignee active in that class. Explore G10L
Ranked #24,143 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cordio Medical Ltd. against Conductix Wampfler France, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.